NEMETHER

This brand name is authorized in Nigeria.

Active ingredients

The drug NEMETHER contains one active pharmaceutical ingredient (API):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7391	Injection	Nemether Injection INJ 80 mg/mL 1ML X 6 AMPOULES	Nemether Injection A4-7391 Nimether ARTEMETHER 80MG/ML DRUG ANTIMALARIA ARTEMETHER 80MG/ML INJECTION 1ML X 6AMPOULES PRESCRIPTION ONLY MEDICINE TREATMENT OF SEVERE MALARIA CHUPET PHARM CO LTD NIGERIA TIANJIN KINGYORK GROUP HUBEI TIANYO PHARMA. CO. LTD CHINA 10/22/2022 21/10/2027	22/10/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BE02	Artemether	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BE Artemisinin and derivatives
Discover more medicines within P01BE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7391